EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

Journal of Clinical Lipidology

ISSN 1933-2874 · Elsevier BV

Latest articles

  1. GPIHBP1 autoantibody positivity in patients with recurrent severe hypertriglyceridemia: Frequency, phenotype, and derivation of an exploratory screening score

    José Rioja, Daniel de la Cueva-Genovés, María José Ariza, Rosa María Ordóñez-Simón, María José Benítez-Toledo, Javier Espíldora-Hernández, Gema Gutiérrez-Lara, Andrés González-Jiménez, Daniel Zambón-Rados, Emilio Ortega-Martínez de Victoria, Daiana Ibarretxe, Ovidio Muñiz-Grijalvo, Teresa Arrobas-Velilla, Pablo Rodríguez de Vera-Gómez, Ana Camacho-Carrasco, Pablo González-Bustos, José Alfredo Martín-Armas, Alejandro Escudero-Contreras, Carlos Alberto Aguilar-Salinas, Inmaculada Coca-Prieto, Miguel Ángel Sánchez-Chaparro

    Published: 2026-10DOI: 10.1016/j.jacl.2026.10.006

  2. Diagnostic performance of serum sterols, including oxysterols, for identifying cerebrotendinous xanthomatosis and monitoring treatment efficacy

    Rieko Sagara, Satoshi Hirayama, Yoshifumi Fukushima, Tsuyoshi Ueno, Naoko Kuwabara, Saori Nakagawa, Hayato Tada, Shingo Koyama, Kazuyuki Noda, Minoru Takemoto, Tomoyo Hashimoto, Yukio Iwanaka, Hiroaki Adachi, Yukihito Higashi, Yoshiki Sekijima, Takashi Miida, Atsushi Hori, Mayumi Idei, Tatsuya Maruhashi, Tomohiro Miyazaki, Masaki Matsubara, Katsuya Nakamura, Masatsune Ogura, Shinji Sato, Ryosuke Tani, Takao Takeshima, Jun-ichi Miyahara

    Published: 2026-09DOI: 10.1016/j.jacl.2026.06.021

Volumes

2026 · 3272025 · 3962024 · 2382023 · 2132022 · 2222021 · 1722020 · 2172019 · 2302018 · 2862017 · 3122016 · 2982015 · 2362014 · 1952013 · 1922012 · 1682011 · 1812010 · 1682009 · 1122008 · 5852007 · 121

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.